Indication

Rectal Chlamydia trachomatis infection

Rectal *Chlamydia trachomatis* infection is a sexually transmitted bacterial infection of the lower gastrointestinal tract, specifically targeting the columnar epithelial lining of the rectum. Read more about Rectal Chlamydia trachomatis infection

213 drugs 106 manufacturers

Advertisement

Drugs that treat it

Common Rectal Chlamydia trachomatis infection therapies.

Showing 10–18 of 213 drugs

Filter & compare in the drug finder →Opens the drug finder with Rectal Chlamydia trachomatis infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Rectal Chlamydia trachomatis infection.

Rectal *Chlamydia trachomatis* infection is a sexually transmitted bacterial infection of the lower gastrointestinal tract, specifically targeting the columnar epithelial lining of the rectum.

It most commonly occurs in men who have sex with men and in women following receptive anal intercourse or autoinoculation from concurrent urogenital infection.

While the majority of cases remain asymptomatic, symptomatic infections typically manifest as proctitis characterized by rectal pain, tenesmus, mucoid or mucopurulent discharge, constipation, and rectal bleeding.

More invasive strains, such as the lymphogranuloma venereum serovars, can cause severe ulcerative proctocolitis, deep tissue inflammation, and downstream lymphatic obstruction.

Personalize your experience

Follow Rectal Chlamydia trachomatis infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it